NDC Product
Human Prescription DrugTradjenta NDC 50090-4383
- Generic Name
- Linagliptin
- Dosage Form
- Tablet, Film Coated
- Route
- Oral
- Marketing
- NDA
Active Listing
LINAGLIPTIN
UNII 3X29ZEJ4R2
Substance Identification & Data
This profile provides standardized clinical and technical data for Linagliptin, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 3X29ZEJ4R2.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 668270-12-0 and the RxNorm Concept ID (RxCUI) 1100699. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
Preferred Name
LINAGLIPTIN
Official standardized name for this substance within the FDA UNII nomenclature system.
Molecular Formula
3X29ZEJ4R2
The specific atomic composition represented as a molecular structure string.
InChIKey
C25H28N8O2 International Chemical Identifier digital signature for unique molecular identification.
SMILES String
LTXREWYXXSTFRX-QGZVFWFLSA-N Line notation for describing the chemical structure and connectivity of atoms.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
INN ID
9039
Sequential identifier assigned via the WHO International Nonproprietary Name program.
USAN ID
WW-122
Identifier assigned by the United States Adopted Names Council.
Substance Type
chemical
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).
Ingredient Role
CC#CCn1c2c(nc1N3CCC[C@H](C3)N)n(C)c(=O)n(Cc4nc(C)c5ccccc5n4)c2=O
Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for Linagliptin. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.
FDA Official Name
LINAGLIPTIN
Common Names & Synonyms
LINAGLIPTIN [INN]
LINAGLIPTIN [JAN]
LINAGLIPTIN [MART.]
LINAGLIPTIN [MI]
LINAGLIPTIN [ORANGE BOOK]
LINAGLIPTIN [USAN]
LINAGLIPTIN [VANDF]
LINAGLIPTIN [WHO-DD]
Brand / Trade Names
GLYXAMBI COMPONENT LINAGLIPTIN
TRAJENTA
TRAZENTA
TRIJARDY XR COMPONENT LINAGLIPTIN
Systematic Nomenclature
(R)-8-(3-AMINO-PIPERIDIN-1-YL)-7-BUT-2-YNYL-3-METHYL-1-(4-METHYL-QUINAZOLIN-2-YLMETHYL)-3,7-DIHYDRO-PURINE-2,6-DIONE
1H-PURINE-2,6-DIONE, 8-((3R)-3-AMINO-1-PIPERIDINYL)-7-(2-BUTYN-1-YL)-3,7-DIHYDRO-3-METHYL-1-((4-METHYL-2-QUINAZOLINYL)METHYL)-
1H-PURINE-2,6-DIONE, 8-((3R)-3-AMINO-1-PIPERIDINYL)-7-(2-BUTYNYL)-3,7-DIHYDRO-3-METHYL-1-((4-METHYL-2-QUINAZOLINYL)METHYL)-
8-((3R)-3-AMINOPIPERIDIN-1-YL)-7-(BUT-2-YN-1-YL)-3-METHYL-1-((4-METHYLQUINAZOLIN-2-YL)METHYL)-3,7-DIHYDRO-1H-PURINE-2,6-DIONE
Technical Codes
BI 1356
BI 1356 BS
BI1356
BI-1356
BI-1356BS
BI-1356-BS
BS 1356 BS
BS-1356-BS
NDC Products Containing LINAGLIPTIN
This unique ingredient identifier is listed as an ingredient or substance in the following products in the NDC directory:
